Penumbra Inc
PEN261.030USD
+4.529+1.77%
Cierre 06/16, 16:00（ET）Cotizaciones retrasadas 15 min
10.10BCap. mercado
720.64P/E TTM
Más Datos de Penumbra Inc Compañía
Penumbra, Inc. is a thrombectomy company, which is focused on developing technologies for challenging medical conditions, such as ischemic stroke, venous thromboembolism, such as pulmonary embolism, and acute limb ischemia. The Company's broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe. It focuses on developing, manufacturing and marketing novel products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. Some of the conditions it focuses on are Pulmonary Embolism, Deep Vein Thrombosis, Acute Limb Ischemia, Ischemic Stroke, Acute Coronary Syndrome, and Clot associated with Arteriovenous Graft or Fistula. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Información de la empresa
Símbolo de cotizaciónPEN
Nombre de la empresaPenumbra Inc
Fecha de salida a bolsaSep 18, 2015
Fundada en2004
Director ejecutivoMr. Adam Elsesser, J.D.
Número de empleados4500
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 18
DirecciónOne Penumbra Place
CiudadALAMEDA
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94502
Teléfono15109952486
Sitio Webhttps://www.penumbrainc.com/
Símbolo de cotizaciónPEN
Fecha de salida a bolsaSep 18, 2015
Fundada en2004
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
947.94K
+1.29%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
302.26K
-3.82%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
52.14K
-1.14%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.87K
-2.01%
Ms. Surbhi Sarna
Ms. Surbhi Sarna
Independent Director
Independent Director
3.15K
-1.84%
Ms. Maggie S. Yuen
Ms. Maggie S. Yuen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Thomas C. (Tom) Wilder, III
Mr. Thomas C. (Tom) Wilder, III
Presiding Independent Director
Presiding Independent Director
--
--
Mr. Harpreet S. Grewal
Mr. Harpreet S. Grewal
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
947.94K
+1.29%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
302.26K
-3.82%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
52.14K
-1.14%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.87K
-2.01%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de abr
Divisa: USDActualizado: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Thrombectomy
815.48M
68.26%
Embolization and Access
379.14M
31.74%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
902.07M
75.51%
International
292.55M
24.49%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Thrombectomy
815.48M
68.26%
Embolization and Access
379.14M
31.74%
Estadísticas de accionistas
Actualizado: lun., 19 de may
Actualizado: lun., 19 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.77%
The Vanguard Group, Inc.
9.47%
BlackRock Institutional Trust Company, N.A.
9.11%
State Street Global Advisors (US)
3.09%
T. Rowe Price Associates, Inc.
3.04%
Other
62.52%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.77%
The Vanguard Group, Inc.
9.47%
BlackRock Institutional Trust Company, N.A.
9.11%
State Street Global Advisors (US)
3.09%
T. Rowe Price Associates, Inc.
3.04%
Other
62.52%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
50.29%
Investment Advisor/Hedge Fund
30.30%
Hedge Fund
6.74%
Individual Investor
3.54%
Pension Fund
1.71%
Research Firm
1.40%
Sovereign Wealth Fund
0.63%
Bank and Trust
0.53%
Venture Capital
0.17%
Other
4.70%
Participación institucional
Actualizado: lun., 20 de ene
Actualizado: lun., 20 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
851
36.94M
95.40%
-4.28M
2024Q4
834
37.02M
96.10%
-3.78M
2024Q3
813
37.33M
96.12%
-2.93M
2024Q2
796
37.57M
96.93%
+395.13K
2024Q1
777
35.67M
92.18%
-2.09M
2023Q4
759
36.33M
94.13%
-67.98K
2023Q3
737
35.15M
91.46%
-2.09M
2023Q2
719
36.20M
94.64%
-1.94M
2023Q1
681
37.31M
97.62%
-964.82K
2022Q4
661
36.89M
97.22%
+885.45K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
4.85M
12.6%
-93.71K
-1.89%
Dec 31, 2024
The Vanguard Group, Inc.
3.64M
9.46%
-25.90K
-0.71%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
3.50M
9.08%
+25.93K
+0.75%
Dec 31, 2024
State Street Global Advisors (US)
1.20M
3.12%
-33.45K
-2.71%
Dec 31, 2024
T. Rowe Price Associates, Inc.
1.23M
3.21%
-702.67K
-36.27%
Dec 31, 2024
Elsesser (Adam)
985.33K
2.56%
+22.75K
+2.36%
Mar 19, 2025
Fidelity Institutional Asset Management
965.15K
2.51%
+16.18K
+1.71%
Dec 31, 2024
Champlain Investment Partners, LLC
1.50M
3.88%
-52.02K
-3.36%
Dec 31, 2024
RTW Investments L.P.
862.45K
2.24%
+66.70K
+8.38%
Dec 31, 2024
Citadel Advisors LLC
734.29K
1.91%
+322.26K
+78.22%
Dec 31, 2024
Ver más
ETFs relacionados
Actualizado: vie., 6 de jun
Actualizado: vie., 6 de jun
Nombre
Proporción
Motley Fool Small-Cap Growth ETF
3.68%
First Trust Health Care Alphadex Fund
2.24%
Congress SMid Growth ETF
2.21%
First Trust Indxx Medical Devices ETF
1.84%
ROBO Global Healthcare Technology & Innovation ETF
1.82%
SPDR S&P Health Care Equipment ETF
1.79%
Tema Neuroscience and Mental Health ETF
1.78%
Putnam Sustainable Future ETF
1.53%
iShares U.S. Medical Devices ETF
1.24%
ProShares Metaverse ETF
1.16%
Ver más
Motley Fool Small-Cap Growth ETF
Proporción3.68%
First Trust Health Care Alphadex Fund
Proporción2.24%
Congress SMid Growth ETF
Proporción2.21%
First Trust Indxx Medical Devices ETF
Proporción1.84%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.82%
SPDR S&P Health Care Equipment ETF
Proporción1.79%
Tema Neuroscience and Mental Health ETF
Proporción1.78%
Putnam Sustainable Future ETF
Proporción1.53%
iShares U.S. Medical Devices ETF
Proporción1.24%
ProShares Metaverse ETF
Proporción1.16%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
